Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis

Fig. 2

Comparison of improvements in disease activity indicators between patients with rheumatoid arthritis (RA) with and without chronic hepatitis B virus infection (CHB). a–l Compared with the non-CHB group, patients with RA in the CHB group experienced significantly smaller improvements from baseline in most disease activity indicators mainly at month 12 (including PtGA, PrGA, Pain VAS, HAQ-DI, DAS28-CRP, SDAI, and CDAI), in TJC28 at month 1, and especially RAPID3 at almost each point except month 3, but no significant improvements were observed in SJC28, CRP, or ESR. *p < 0.05, **p < 0.01. CDAI Clinical Disease Activity Index, CRP C-reactive protein, DAS28 Disease Activity Score 28-joint assessment, ESR Erythrocyte sedimentation rate, HAQ-DI Stanford Health Assessment Questionnaire Disability Index, Pain VAS Pain visual analogue scale, PrGA Provider global assessment of disease activity, PtGA Patient global assessment of disease activity, RAPID3 Routine Assessment of Patient Index Data 3, SDAI Simplified disease activity index, SJC28 28-joint swollen joint count, TJC28 28-joint tender joint count

Back to article page